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ABSTRACT
Rickettsia felis, the causative agent of flea-borne spotted fever, is an emerging pathogen
of the transitional group Rickettsiae and an important cause of febrile illness in Africa. Since the
organism’s original discovery in the early 1990s, much research has been directed towards
elucidating transmission mechanisms within the believed primary host and reservoir, the cat flea
(Ctenocephalides felis). However, while a growing number of human cases are being reported
throughout the world, a definitive transmission mechanism from arthropod host to vertebrate
host resulting in clinical disease has not been found. Several possible mechanisms, including bite
of infected arthropods and association with infectious arthropod feces, are currently being
investigated. This current study was undertaken to examine the role of infectious cat flea feces in
dissemination of the organism to vertebrates. It was hypothesized that if cat fleas excrete viable
R. felis during feeding, then the feces are capable of producing infection in vertebrates through
cutaneous inoculation. Feces of cat fleas infected with R. felis were analyzed for the presence of
the organism, and these potentially infectious feces were then used to intradermally inoculate
naïve BALB/c mice. The results of this research show that R. felis is present in high numbers in
infected cat flea feces post-exposure to an infectious blood meal, and these bacteria are presumed
viable due to the detection of rickettsial transcripts within the feces. Detectable amounts of R.
felis were found in the skin of mice inoculated both with R. felis from culture and R. felisinfected flea feces, and rare animals injected with R. felis from culture showed possible systemic
dissemination. The response of mice inoculated with R. felis-infected cat flea feces is primarily a
neutrophilic dermatitis with positive anti-Rickettsia IgG titers at 14 days post-exposure. No mice
developed any overt clinical or physical signs. This study demonstrates that cutaneous
inoculation with infectious arthropod feces is an effective transmission medium for the organism
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to mice. Further work is needed to define the role of this route of exposure in the epidemiology
of the human disease.
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CHAPTER 1: RICKETTSIA FELIS: A REVIEW OF TRANSMISSION MECHANISMS
OF AN EMERGING PATHOGEN1
1.1. Introduction
Rickettsia felis, an obligate intracellular bacterium of the transitional group Rickettsia, is
the causative agent of emerging flea-borne spotted fever [1]. This organism was first associated
with human disease in a patient from Texas in 1994 [2], and human cases have since been
reported on every continent except for Antarctica [3]. The widespread nature of the disease is
likely secondary to the believed primary vector and reservoir host, the cat flea (Ctenocephalides
felis), which shares a similar pervasive range (Figure 1). While much work has been done to
investigate the spread of R. felis between cat fleas and to vertebrate hosts, a definitive
transmission mechanism that produces a rickettsemic host with clinical signs that mimic the
human disease has yet to be found.
Recent studies have associated R. felis to infection and febrile illness in Africa, with up to
15% of patients with fever of unknown origin having detectable levels of R. felis in their blood
via PCR analysis [4]. There have also been recent outbreaks of flea-borne ricketssiosis in the
United States, including Texas, California, and Hawaii, where data has shown R. felis to be more
prevalent in arthropods and mammals via PCR analysis in the area than R. typhi (the etiologic
agent of murine typhus) [5-7]. Murine typhus is another flea-borne rickettsioses, of the typhus
group Rickettsia, causing a disease clinically indistinguishable from R. felis. This agent also has
endemic foci in southern California and south Texas [4]. Given the similarities in clinical
presentations and location of outbreaks, it is evident how many of these cases could be confused
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Figure 1. Reported distribution of R. felis in the world.
R. felis-positive arthropods have been reported in (blue): Afghanistan, Albania, Algeria, Argentina,
Australia, Canada, Chile, Colombia, Croatia, Cyprus, Czech Republic, Democratic Republic of
Congo, Ethiopia, Gabon, India, Indonesia, Israel, Italy, Ivory Coast, Japan, Lebanon, Malaysia,
Morocco, Panama, Peru, Portugal, Romania, United Kingdom, and Uruguay. Along with infected
arthropods, human cases of R. felis have been reported in (red): Australia, Brazil, China, France,
Germany, Kenya, Laos, Mexico, New Zealand, South Korea, Spain, Taiwan, Thailand, Tunisia, and
the United States. Human cases without detection of infected arthropods have been reported in
(green): Egypt, Nepal, and Sweden.

with each other, as well as other similar rickettsial diseases. The advent of more sophisticated
diagnostic techniques has aided in the distinction of some of these cases [8], allowing for a
clearer clinical picture of flea-borne spotted fever.
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1.2. Background
Rickettsiosis is caused by bacteria of the genus Rickettsia, which includes the spotted
fever group (SFG), typhus group (TG) and, a more recent classification, transitional group
(TRG) [9]. Rickettsia spp. are most commonly divided into the SGF or TG based on their vector
of transmission, antigenic characteristics, optimal growth temperatures, percent G+C DNA
contents, and clinical features [10]. Bacteria associated with the SFG are usually transmitted to
vertebrates via the bites of hard ticks, while members of the TG are predominantly transmitted
by contamination of mucous membranes, conjunctivae, and/or open wounds with the infectious
feces of lice and fleas [11]. Rickettsia felis was originally charactized as a typhus-like Rickettsia
due to the fact that the first human case was originally misdiagnosed as murine typhus and the
organism was initially isolated from a laboratory flea colony. Additionally, early analysis of the
17-kDA and citrate synthase genes of R. felis supported a TG classification [12]. However, later
analysis revealed the presence of the ompA gene and a 17-kDA gene having more similarity to
the SFG rather than TG [1]. There has been some debate in the literature as whether to classify R.
felis as TRG Rickettsia or a SFG variant. While some agree with the creation of a third group of
Rickettsia spp. (TRG), others still classify R. felis as a SFG Rickettsia sp. The latter classification
for R. felis as a SFG-variant coincides with other organisms that also are transmitted by
arthropods other than ticks (e.g. R. felis-like organisms and R. hoostraalii) [11]. The difficulty in
even classifying this emerging pathogen helps display part of the obstacles that many have had in
distinguishing R. felis from other related bacteria in both clinical and laboratory settings.
1.3. Clinical Disease
The clinical manifestation of several rickettsioses, specifically R. felis and R. typhi, have
many similarities, including headache, chills, fever, myalgia, and malaise, with a large number of
3

patients presenting with a maculopapular rash [4]. Few cases have presented with an “eschar,”
which is a single crusted, cutaneous lesion surrounded by a halo, thought to represent the site of
inoculation via an arthropod [13]. It has been reported that the percentage of patients that present
with rashes and eschars (75% and 13%, respectively) is higher in cases of R. felis compared to R.
typhi [4]. Rarely, R. felis has also been associated with neurologic signs (including a
polyneuropathy-like syndrome and subacute meningitis), pneumonia, and gastrointestinal
symptoms [14]. To date, there have been no reports of R. felis causing more serious
complications or death [1]. However, the similarity of flea-borne spotted fever symptoms to R.
typhi and other vector-borne diseases, as well as the lack of specific diagnostics, has potentially
led to an underdiagnosis of R. felis in many human cases.
As stated previously, R. felis has been reported as an emerging cause of fever of unknown
origin in Africa. However, given the fact that R. felis has also been detected in skin swabs from
afebrile patients in Africa [15], it has been suggested that the organism is ubiquitous in the area
and its true pathogenecity has been questioned [16]. To explain the variable presentations, it has
been proposed that patients in Africa exhibit a more chronic form of the disease, with diseasefree intervals interspersed with periods of relapse (similar to malaria- which shares a common
epidemiology to R. felis in certain areas of Africa) [14]. Adding to the perplexing nature of R.
felis in Africa, several studies performed in areas of outbreaks have surprisingly not been able to
detect R. felis in local cat fleas [14]. The organism was, however, able to be detected in multiple
species of mosquitoes, including several Anopheles spp. Survey studies in the area have shown a
correlation between the locations R. felis-infected mosquitoes and human infections [17], as well
as a correlation between infected mosquitoes and prevelance of R. felis in ape feces [18],
suggesting a potential role for alternate hosts in the disease ecology in Africa.
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One of the strongest correlations between R. felis and human disease in Africa came from
a recent case study that described a vesicular fever in an 8-month old girl in Senegal [15]. The
patient erupted in vesicles and ulcers over her entire body and presented with a fever. Swabs
were performed of the cutaneous lesions, which were found to be qPCR-positive for R. felis,
although qPCR results were negative in the blood samples. Additionally, sera samples collected
from time points prior to infection, as well 40-days post-presentation, were negative for R. felis
antibodies via IFA and Western blot analysis. Given the lack of seroconversion of the patient,
this was described as a primary infection of R. felis causing the clinical cutaneous presentation.
Researchers proposed the term “yaaf” to idenfity the clinical entity, the Senegalese word for
vesicle [15]. Another case of a primary infection was described previously in the Yucatan, with
similar lesions, suggesting the specific cutaneous lesions may be pathognomonic for R. felis [19].
The inability to isolate R. felis from blood, even in acutely ill patients, has been thought to
preclude a definitive link between the organism and disease. However, these recent case studies
have shown that there is a possible alternative route to disease that does not include circulating
blood-borne rickettisal organisms.
1.4. Transmission to Arthropods
To date, thirty-nine species of arthropods have been associated with R. felis, including
several different species of fleas, ticks, lice, and mosquitoes [20]. However, the cat flea
(Ctenocephalides felis) has been shown to serve as not only the primary vector, but seemingly
the reservoir of R. felis in the environment as well [3, 21]. The maintenance of R. felis within
laboratory colonies of cat fleas has been extensively studied and was originally attributed mainly
to vertical transmission, or the transmission of pathogen from parent to offspring [12, 22]. Strong
evidence for this mechanism was given when R. felis was found to be present in both male and
5

female cat flea reproductive tissue, including the ovaries and epithelial sheath of the testes [23].
Rickettsia felis was first shown to undergo transovarial transmission, with detection of R. felis in
freshly-deposited cat flea eggs [12], followed by the exhibition of R. felis in newly emerged
unfed adult cat fleas, demonstrating transstradial transmission [24]. However, vertical
transmission of R. felis to the progeny of cat fleas has reported to be highly variable, with several
studies demonstrating the inability of cat fleas to maintain vertical transmission of R. felis when
exposed as adults [22, 25, 26]. While observed variability in vertical maintenance is likely a
laboratory artifact, this lack of transmission to progeny during infection bioassays suggests
alternate mechanisms to introduce and maintain R. felis in vector populations likely exist.
The ability to undergo frequent horizontal (infectious) transmission has been shown to be
more prevelant in virulent rickettsiae species [27]. Multiple mechanisms for horizontal
tranmission have been elucidated for R. felis within cat fleas, as well as other invertebrate hosts.
A prerequisite to successful horizontal transmission is oral acquisition of R. felis. This was
demonstrated by an experiment exposing unifected cat fleas to an R. felis-infected bloodmeal in
an artificial host system, where cat fleas were shown not only to be able to acquire the the
infection, but also remain persistently infected for up to 28 days post-exposure [22].
Demonstration of transmission through a shared blood meal was confirmed via an experiment
where cat fleas, both infected and uninfected, fed on an artificial host. Uninfected cat fleas
became infected with R. felis at varying rates (3.3-40.0%), as early as 24-hours post-exposure to
infected fleas [26]. In this experiment, it was also shown that cat fleas could become infected
through mating with infected cat fleas without exposure to any infectious bloodmeal. Cofeeding,
which is the successful horizontal tranmission of pathogens between actively blood-feeding
arthropods in the absence of a disseminated vertebrate infection, has also been demonstrated in
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cat fleas infected with R. felis. Infected (donor) cat fleas were placed in either the same capsules
(co-fed) or different capsules (cross-fed) as uninfected (recipient) cat fleas on an uninfected
murine host. Recipient cat fleas were shown to acquire the infection in both co-fed and cross-fed
models in absence of the murine hosts becoming rickettsemic. Interestingly, the experiment also
revealed that infected cat fleas were able to transmit R. felis to naïve rat fleas (Xenopsylla
cheopis) [3].
There has been further investigation into the specific mechanism of horizontal
transmission of R. felis between cat fleas. Support for salivary transmission was found when R.
felis was detected via qPCR in the salivary gland of cat fleas that had been feeding on cats for 24 days [28]. Definitive evidence for salivary gland localization within cat fleas was given when
rickettsial organisms were visualized via IFA in salivary glands in previously uninfected cat fleas
7-14 days post-exposure to an infectious blood meal [29]. Given these findings, as well as the
previously discussed studies on co-feeding, there is strong evidence for R. felis transmission
through infectious saliva in cat fleas (e.g. biological transmission). Recent evidence for
mechanical transmission has also been demonstrated in cat fleas. Previously uninfected cat fleas
were shown to be infectious to naïve cat fleas as early as 24 hours post-exposure to an infectious
blood meal, indicating early-phase transmission. In addition, R. felis was not able to be detected
in the salivary glands of these infectious cat fleas and the organism was shown to be released
from contaminated mouthparts during probing [30].
While R. felis is primarily transmitted by C. felis, multiple field studies have
demonstrated molecular detection of the infectious agent in not only other species of fleas, but
also ticks, mites, and mosquitoes [13, 30]. However, it is unclear whether these other arthropods
contribute to the ecology of R. felis, or if their R. felis-infection is transient and insignificant in
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transmission [21]. Recently, ticks exposed to R. felis maintained rickettsiae for one generation,
but transmission was not stable [31]. Likewise, Anopheles gambiae mosquitoes demonstrated the
ability to sustain an infection for up to 15 days, but stable transmission was not observed [32].
Various genotypes of R. felis have also been isolated from several of these other non-flea
arthropods [21], including a novel strain of R. felis that was identified in the non-blood-feeding
booklouse, Liposcelis bostrychophila [33, 34]. This strain of R. felis (str. LSU-Lb) has been
shown to have to ability to not only infect cat fleas, but also undergo vertical transmission within
these arthropods as well [25]. Genetic variation was not only found between strains isolated from
different hosts (e.g. cat flea vs. booklouse), but also from strains isolated from the same host at
different geographic locations [27]. Interestingly, R. felis seems to have a different effect on the
host depending on the vector. As stated previously, vertical transmission of R. felis in C. felis has
been highly variable, suggesting that this organism has a negative fitness effect on the arthropod
population, requiring additional horizontal tranmission for pathogen maintance. However, in the
booklouse, R. felis has been shown to be maintained 100% transovarially, and clearance of the
organism from adults actually resulted in decreased longevity, fecundity, and non-viable egg
production [33, 35]. Given the variation reported within arthropods, further work investigating
the effect of strain variation within various arthropod species must still be done.
1.5. Transmission to Vertebrates
While several transmission mechanisms within arthropods have been described in
relation to infection with R. felis, the means by which vertebrates acquire an infection from these
arthropods remains unclear. Transmission of flea-borne pathogens is often multifactorial, with
each species having several transmission routes to ensure maintenance [20]. The most common
route of flea-borne pathogen transmission to vertebrates is through the bite of an infected
8

arthropod. Evidence that this could be a possible infection route for R. felis in C. felis was given
by demonstrating the organisms within the salivary glands of fleas [28, 29]. Further, naïve cats
exposed to cat fleas infected with R. felis seroconverted after four months, and R. felis DNA was
detected via qPCR in the blood of 5/16 of these cats [36]. However, definitive culture of the
organism from the blood of exposed cats could not be obtained. A survey study that sampled
over 100 cats from several states in the United States found none to have detectable levels of R.
felis in the blood, however, one cat did have detectable levels on the skin and another on the
gingiva [37]. The cutaneous presence of R. felis in one feline patient, combined with the lack of
circulating organisms, is reminiscent of the cutaneous presentation of human patients in Africa
and the Yucatan, although no cutaneous lesions were reported in the cat.
Another possible mechanism for vertebrate infection is via infectious vector feces.
Excretion of viable rickettsiae in feces of infected arthropods has been found to be crucial in the
tranmission for other species, including Rickettsia prowazekii and Rickettsia typhi. The most
common form of exposure to infectious arthropod feces is through cutaneous inoculation, either
through the deposition of arthropod feces at the bite site or contamination of broken skin or
wounds with feces. Transmission of R. prowazekii has been demonstrated to occur via
scarification of a louse bite site with rickettsiae-laden feces [38], and cutaneous inoculation of
feces from fleas infected with R. typhi has been shown to create infections in rat and man (with
as little as 0.2 mg of flea feces producing infection) [39, 40]. A closely related bacteria,
Bartonella hensalae, has also been shown to use this tranmission mechanism for dissemination
to vertebrates. Feces from cat fleas infected with the bacterium caused cats to become bacteremic
1-2 weeks post intradermal injection, as well as caused seroconversion by 20 weeks postinjection [41].
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There is evidence to suggest that R. felis is also transmitted via infectious flea feces. Eggfree feces from R. felis-infected C. felis fleas was assessed at days 2-28 post-exposure to an
infectious blood meal. R. felis gDNA was detected at most time points throughout the study via
qPCR amplification of the 17-kDa gene. Additionally, there is evidence that these are viable,
transcriptionally active rickettsial organisms because a R. felis transcript was detected in the
feces at 21 days post-exposure to an infectious bloodmeal [22]. Further work with vertebrates
must be performed to determine if this is a possible R. felis transmission mechanism in vivo.
It is difficult to study transmission of R. felis to vertebrate hosts because a definitive host
with appropriate clinical signs and bacteremia has not been found. Several animals, including
cats, dogs, opossums, raccoons, rodents, and humans, have been found to be either seropositive
or PCR-positive for R. felis DNA. Additionally, the cat flea lacks true host specificity, and R.
felis-infected arthropods have been recovered from cats, dogs, rodents, opossum, hedgehogs,
horses, sheep, goats, gerbils, and monkeys [30]. Given the lack of a definitive mammalian host,
many research experiments have looked at transmission of R. felis from cat fleas to vertebrates
using rodents, including mice and rats. Information about choice of mouse strain could be taken
by previous experiments performed on related species, such as Rickettsia parkeri, a member of
the SFG rickettsiae. Several strains of inbred mice, including A/J, BALB/c, C3H/HeJ, and
C3H/HeN, were studied to determine their response to intravenous and intradermal inoculation
of R. parkeri [42]. The only strain to show pathology consistent with sustained infection was
C3H/HeN, which exhibited marked facial edema and splenomegaly, as well as characteristic
eschar-like lesions. Given this information, the C3H/HeN strain was more extensively studied
with regards to R. felis infection. Post-intravenous incoulation with a high-dose of R. felis (1x106
organisms), C3H/Hen mice had detectable levels of rickettsial DNA in the spleen and liver as
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early as 1 day post-inoculation. Levels decreased to 50% or less by 6- and 14-days post injection.
Rickettsia felis DNA was never detected in the blood of the mice, and no mice exhibited any
overt clinical signs of illness or pathology [Macaluso, Unpublished]. This mouse strain was also
used in the previously described cofeeding experiment, where mice received an interdermal
inoculation with 5x109 rickettsiae from culture. Mice in this study also did not show any
evidence of clinical signs or R. felis DNA in their blood, although other organs including liver
and spleen were not tested for presence of R. felis gDNA [3].
A recent study looked at another mouse strain, BALB/c, in regards to the ability to
acquire an R. felis infection. This study actually utilized mosquitoes, Anopheles gambiae, to
examine transmission to vertebrates. This approach was undertaken to further investigate the
paradox of the low number of infected cat fleas found in areas of high R. felis prevalence in
Africa. Natural bites from R. felis-infected A. gambiae mosquites were shown to produce a
transient rickettsemia in BALB/c mice, confirmed via qPCR analysis of the blood [32]. The
bacteremia was present in a majority of the mice both 1 and 2 days after being exposed to
infected mosquitoes, but disappeared by day 3. However, even though this mouse model was
able to acquire an infection, no clinical signs or physical changes were reported in these mice.
While several of these mouse models have shown some promise, it is apparent that a definitive
laboratory model that mimics the clinical disease in humans has yet to be found.
1.6. Discussion
It is clear that there is still much to be understood about Rickettsia felis. While the cat flea
is still believed to be the primary reservoir and vector of the organism worldwide, the discovery
of multiple arthropods that harbor the pathogen reveals the need to do more extensive field
research, including analysis of all possible arthropods in the area of reported human disease. A
11

more complete picture of the possible vectors of human disease could propel research in the right
direction. In addition, given that multiple transmission mechanisms within C. felis have been
elucidated, it is possible that the transmission of R. felis within and amongst other arthropods is
equally as complicated and multifactorial. Experiments that include transmission of the organism
to multiple vectors might more closely mimic what is happening in nature. The most perplexing
question that remains to be answered is how humans are acquiring the infection. While bites
from infected cat fleas were previously thought to be the most likely mechanism, multiple
laboratory experiments have not been able to produce a rickettsemic vertebrate with clinical
signs that mimic a human infection through this route. It is important to note, given the findings
in Africa of non-rickettsemic patients that exhibit clinical signs, an appropriate laboratory model
may also not show evidence of R. felis infection in the blood. Also, mammals may simply be
asymptomatic reservoirs. Further research with vertebrates, such as association with other R.
felis-infected arthropods or contact with infectious arthropod feces, might aid in answering these
questions and discovering a definitive, disease-causing transmission mechanism from arthropod
to human.
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CHAPTER 2: TRANSMISSION POTENTIAL OF RICKETTSIA FELIS TO
VERTEBRATES VIA CUTANEOUS INOCULATION OF INFECTIOUS FLEA FECES
2.1. Introduction
Rickettsia felis is a gram-negative, intracellular bacterium of the transitional group
Rickettsiae and the causative agent of flea-borne spotted fever [1]. Clinical presentations of this
disease in humans vary widely, ranging from asymptomatic carriers in Africa [15, 16], to mild
fevers and dermal lesions [4], to finally the most severe manifestations including pneumonia and
neurologic signs [14]. Diagnosis of the disease has previously been through somewhat indirect
methods, including PCR of both skin lesions [15] and blood from diseased individuals [4], as
well as serology. However, the inability to isolate R. felis from the blood of acutely ill patients
and lack of a definitive link between the organism and disease has led some to question the
pathogenicity of the organism [16]. An alternative route to disease that does not include bloodborne rickettsial organisms has been proposed, termed “yaaf,” after the Senegalese word for
vesicle [15]. This suggestion is based on a case report from Africa where an infant girl erupted in
vesicles and ulcers over her body and presented with a fever. While the cutaneous lesions from
the girl were found to be PCR-positive for R. felis, blood samples were negative for the organism
via PCR and no rickettsial antibodies were detected via serology (including IFA and western blot
analysis). A similar case report from the Yucatán described an adult woman who presented with
cutaneous lesions, along with fever, myalgia, and hearing loss. The skin lesions were PCRpositive for R. felis, while blood samples showed no amplification of rickettsial genes. The
patient also contained no detectable antibodies to Rickettsia in acute serum samples, but
convalescent sera contained antibodies to R. akari, R. rickettsia, and R. typhi [19]. These reports
suggest the possibility of a cutaneous manifestation of the disease that does not depend on a
rickettsemic vertebrate host.
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Adding to the perplexing nature of R. felis is the lack of a definitive transmission method
between arthropod and vertebrates. The organism has been long believed to be transmitted to
humans by the cat flea (Ctenocephalides felis) since its first isolation from a laboratory flea
colony in 1992 [12]. Strong evidence for C. felis as the primary vector and reservoir of R. felis
has been presented, including the finding of numerous R. felis-positive cat fleas in areas of
human outbreaks of flea-borne rickettsiosis [5-7]. While R. felis has been demonstrated in cat
flea salivary glands [28, 29], alternative routes of transmission other than arthropod bites,
including transmission through infectious flea feces, remain to be investigated. Excretion of
viable rickettsiae in feces of infected arthropods has been found to be crucial in the transmission
for other related species, including Rickettsia prowazekii [38] and Rickettsia typhi [39, 40].
Additionally, previous work has demonstrated that potentially viable R. felis organisms are
excreted in the feces by C. felis [22]. Thus, it was hypothesized that if cat fleas excrete viable R.
felis after exposure to the organism, then the feces would be capable of producing infection in
vertebrates through cutaneous inoculation. This study was undertaken to further investigate the
presence of R. felis in infected cat flea feces and the role of these infectious flea feces in the
transmission of R. felis to vertebrates. In this experiment, the feces of cat fleas previously
exposed to R. felis-infected bloodmeals were examined for the presence of R. felis DNA and
RNA. The potentially infectious flea feces were then intradermally inoculated into naïve
BALB/c mice, and the effects of these feces were compared to R. felis-free feces, as well as to R.
felis from culture, over a period of 14 days.
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2.2. Materials & Methods
2.2.1. Source and strains of bacteria, fleas, and mice
The R. felis strain used was originally obtained from the Louisiana State University cat
flea colony (LSU; passage 3) and maintained in Ixodes scapularis embryonic cell line (ISE6) in
modified L15B growth medium as previously described [43]. Rickettsial infections within
culture were monitored weekly using the Diff-Quik staining procedure [43]. Newly-emerged,
Rickettsia-uninfected cat fleas were obtained from Elward II (El-Labs, Soquel, Ca). Five to tenweek-old, mixed-sex, BALB/c mice were obtained from Louisiana State University (Division of
Laboratory Animal Medicine) and used as a murine model organism.
2.2.2. Ethics Statement
This study was carried out in accordance with the following: Animal Welfare Act (9 CFR
Ch. 1 Subpart C 2.31 (c) 1-8), Guide for the care and use of Agriculture Animals in Agricultural
Research and Training (Chap. 1), and the Public Health Service Policy on Human Care and Use
of Laboratory Animals (Section IV.B. (1-8)). All animal research was performed under the
approval of the LSU Institutional Animal Care and Use Committee (IACUC; Protocol Number:
15-115).
2.2.3. Cat flea bloodmeal treatments in the artificial dog unit
Cat fleas were pre-fed 3-4 days on uninfected, defibrinated bovine blood (HemoStat
Laboratories, Dixon, CA) within an artificial dog unit as previously described [44]. Cat fleas
were divided into cages of ~200 fleas each (mixed-sex). All flea cages were changed prior to
exposure to either infectious or control bloodmeal. Prior to infection, a portion of cat fleas from
each cage were tested via quantitative real-time polymerase chain reaction (qPCR) of the R. felis
ompB gene [8] and determined to be R. felis-negative. Following 24 hours of pre-feeding with
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heat-inactivated bovine blood, cat fleas were starved for 5-6 hours, and then given a Rickettsia
felis-infected bloodmeal. To prepare the infectious bloodmeal, following enumeration by the
BacLight viability staining kit (Molecular Probes, Carlsbad, CA), intact R. felis-infected ISE6
cells (containing 5x109 rickettsiae) were pelleted by centrifugation at 13,000 x g for ten minutes,
and then resuspended in 600 µL of HI bovine blood. Cat fleas were allowed to feed on the R.
felis-infected bloodmeal for 48 hours, and then switched to an uninfected bloodmeal for the
remainder of the study. To generate uninfected cat fleas and feces, 2 mL of unaltered (i.e.
without rickettsiae) bovine blood was used as a control treatment.
2.2.4. Collection of flea feces
Following either exposure to infectious bloodmeals or control bloodmeals, cat flea cages
were changed once every seven days for one month, at days 7, 14, 21, and 28-post exposure.
Control cages were always changed before infected cages to avoid cross contamination. At the
time of cage change, the remaining live cat fleas were collected and transferred to clean cages. A
portion of the live cat fleas were collected for future qPCR analysis to determine presence of
rickettsial infection. The dirty cages were inspected both grossly and under a dissection
microscope to remove all dead cat fleas, larvae, and eggs, so only flea feces remained
(“prepared” feces). Flea feces was then scraped from the cages, weighed, and kept in three
separate microcentrifuge tubes for DNA extraction, RNA extraction, and extra for future mouse
inoculations. Flea feces saved for DNA extraction was stored in 500 µL of sterile PBS and stored
at -20°C. Flea feces saved for RNA extraction was stored in 1 mL of TRIzol and stored at -80°C.
If flea feces was to be used for a vertebrate experiment, collection and qPCR analysis of feces
was performed within 24 hours of experiment. While qPCR analysis was being performed, the
extra flea feces was placed into a clean flea cage and put back into the artificial dog unit
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overnight until the next day when the vertebrate experiment was performed (to ensure bacterial
viability). All flea feces used for vertebrate experiments was taken from 14-days post-exposure
to infectious bloodmeals for standardization of the inoculations mice received.
2.2.5. Transmission experiments in BALB/c mice
Eighteen (18) mixed-sex, 5 to 10-week-old BALB/c mice were used for each replicate of
the vertebrate experiments (Figure 2). Fifteen (15) experimental mice were injected
intradermally with either R. felis from culture (cell-free lysate) or R. felis-infected cat flea feces,
mixed with warmed L15B total media, to a total volume of 100 µL. Three (3) control mice were
injected with either L15B total media alone (as a control for R. felis from culture) or R. felis-free
cat flea feces (as a control for R. felis-infected flea feces). Six (6) mice, including 5 experimental
and 1 control, were sacrificed at each of the following time points: 24 hours post-injection, 48
hours post-injection, and 14 days post injection. Mice that were kept for 14 days were monitored
daily for any physical or clinical signs. Both experimental models, including injection of mice
with R. felis from culture and R. felis-infected flea feces, included three replicates. For
intradermal inoculations, both from culture and from feces, an infectious dose of 1x106 R. felis
was calculated per mouse. The infectious dose was based on preliminary data using high passage
R. felis (p. 8) [Legendre, Unpublished] where the average number of R. felis organisms per
milligram of flea feces was found to be approximately 4x104. Given that cat fleas have been
reported to produce ~0.77 mg of feces per day [45], an infective dose that aimed to mimic a
natural infection was calculated based on the amount of feces that could be produced by five
fleas living on a mouse for a week. Inoculations from R. felis from culture were enumerated via
the backlight BacLight viability staining kit, and inoculations from infectious flea feces were
based on qPCR analysis results. For control mice, either L15B total media alone or R. felis-free
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Figure 2. Experimental methods for vertebrate inoculations
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flea feces (confirmed via qPCR) mixed with L15B total media was used. For inoculations, mice
were sedated with Isoflurane and a patch of hair was shaved in the intrascapular region. Mice
were inoculated using a U-100 insulin syringe (Beckton, Dickinson and Company, Franklin
Lakes, NJ). A sharpie marker was drawn around the resulting intradermal bleb to mark the site of
inoculation (Figure 3).

Figure 3. Intradermal inoculation of BALB/c mice.
Site of intradermal inoculation on mice (red arrow), for both R. felis from culture and R. felisinfected cat flea feces. A sharpie mark was utilized to delineate the inoculation site for future
sample collection.
Mice were kept in separate cages based on sex, and control mice were kept separated
from experimental mice. As previously stated, mice were humanely euthanized with carbon
dioxide at 24 hours, 48 hours, and 14 days post-injection. Blood was obtained via cardiac
puncture and full necropsies were performed. Samples from skin both at the inoculation site (i.e.
within the sharpie mark) and away from the inoculation site were aseptically collected and saved
for DNA extraction (microcentrifuge tubes at -20°C), RNA extraction (1 mL of TRIzol at 80°C), and histopathologic evaluation (biopsy cassettes in 10% formalin). Sections of heart,
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spleen, and liver were also collected and saved for DNA extraction and histopathologic
evaluation.
2.2.6. Detection of Rickettsia felis in fleas, flea feces, and mice
Previously collected fleas were surface sterilized prior to DNA extraction, via washing
with 10% bleach for 5 minutes, 70% ethanol for 5 minutes, and finally sterile distilled water for
5 minutes (three times). Fleas were then placed in separate 1.7 mL microcentrifuge tubes and
crushed with sterile plastic pestles in a liquid nitrogen bath. Genomic DNA (gDNA) was
extracted using Qiagen DNeasy Tisue Kit (Qiagen, Germantown, MD) according to the
manufacterer’s instructions for tissue samples and eluted in 30 µL PCR-grade H20. For
extractions from cat flea feces, a portion (10 mg) of “prepared” flea feces was mixed with 500
µL of sterile PBS, followed by the standard protocol for extractions of non-nucleated blood
according to the manufacturer’s instructions. For extraction from mouse tissue, tissue disruption
and homogenization were performed by combining tissue samples with two sterile stainless-steel
beads in a 1.7 mL Safe-Lock microcentrifuge tube containing proteinase K and Buffer ATL for 2
cycles of 3 minutes at 30 Hz in a TissueLyser (Qiagen, Valencia, CA) [42], followed by the
standard tissue extraction protocol according to the manufacturer’s instructions. A negative
environmental control (DNA extraction reagents without a biologic sample) was utilized for each
DNA extraction process. All gDNA preparations were stored at -20°C until further analysis was
performed. Quantitative PCR for detection of the rickettsial ompB gene [8], the C. felis 18S
rRNA gene [22], and mouse cfd gene [42] was performed. The qPCR was performed with a
LightCycler 480 Real-Time PCR system (Roche), and results were presented as quantified
rickettsial copy numbers per sample. For cat flea feces, the rickettsial copy number per sample
was used to calculate the number of organisms per milligram of feces. For all results, if qPCR
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results showed amplification very late in the cycle (> cycle 35), the amplified product was
visualized on 1.5% agarose gel to obtain a band for confirmation. The bands were cut from the
gel and purified using Wizard SV Gel and PCR Clean-Up System (Promega). Purified samples
were submitted for sequencing by the dye terminator method on a 3130 Genetic Analyzer
(Applied Biosystems) at LSU (School of Veterinary Medicine). Nucleotide similarities were
compared using the GenBank database. Environmental controls and control mice were also
subjected to the same process to ensure there was no contamination of samples.
In order to examine the potential viability of R. felis found in both flea feces and mouse
skin, rickettsial RNA was isolated from both “prepared” flea feces and mouse skin (both at and
away from the inoculation sites), as previously described, with minor modifications [3].
Approximately 20 mg of “prepared” feces was combined with 1 mL of TRIZol, and mouse skin
was combined with 1 mL of TRIZol and two stainless steel beads for tissue disruption and
homogenization (as previously described with a TissueLyzer), prior to extraction. Extraction was
performed using chloroform for phase separation, followed by removal of the aqueous phase
(containing RNA), and finally RNA precipitation and wash with isopropanol and 75% ethanol,
respectively. RNA samples were treated twice with DNase I (Promega) according to the
manufacturer’s instruction, followed by RNA clean-up using RNA Clean & Concentrator (Zymo
Research). The treated RNA samples were then used to synthesize cDNA, using iScript cDNA
Synthesis Kit (Bio-Rad). To confirm the absence of DNA contamination, no-RT controls were
included for all samples. Viability of the rickettsial organisms was determined via qPCR
amplification of R. felis ompB from prepared cDNA samples.
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2.2.7. Histopathology and Immunohistochemistry
After formalin fixation, tissue samples were paraffin-embedded and sections were cut for
both hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC) with a polyclonal
anti-Rickettsia antibody (diluted 1/1000) as previously described [42]. Tissue samples analyzed
included any specimens that showed amplification of R. felis ompB via qPCR, as well as sections
from control mice (inoculated with either culture media alone or R. felis-free cat flea feces).
Samples were examined by a board-certified veterinary anatomical pathologist. The degree of
dermatitis and panniculitis (inflammation of subcutaneous fat) were classified as either absent (0;
no lesions noted), mild (+; rare to infrequent at high-power), moderate (++; change is found in
multiple high-power fields or large foci are present in selected areas), marked (+++; changes are
frequently observed in multiple high-power fields or change is severe in focal areas), or severe
(++++, changes are similar to those seen in the previous category, with the addition of extensive
necrosis). Any extensions into the superficial dermis, as well as the type of inflammatory cells
present, were also noted. Immunohistochemistry samples were graded similarly: 0 (no rickettsial
organisms seen), + (rare organisms seen), ++ (moderate numbers of organisms seen), and +++
(many organisms seen).
2.2.8. Enzyme-linked immunosorbent assay (ELISA) on mouse sera
Indirect ELISAs to detect anti-rickettsial IgG were performed on serum samples taken
from mice sacrificed at 14 days post-injection as previously described, with minor modifications
[31, 46]. Serum samples, mixed with blocking buffer (1% bovine serum albumin in 0.1%
Tween-20) to a 1:32 dilution, were added to half of the wells of a 96-well R. parkeri antigencoated plate (Fuller Laboratories, Fullerton, CA). These dilutions were then added to the other
half of the wells, containing 50 µL of blocking buffer, to obtain a 1:64 dilution. Serum from a
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mouse previously inoculated with R. parkeri and wells without serum were used as positive and
negative controls, respectively. After a 1-hour incubation, the plate was washed three times with
washing buffer (0.1% Tween-20 in PBS). A secondary antibody (goat anti-mouse IgG
conjugated to horseradish peroxidase diluted 1:1000 in blocking buffer) was added and allowed
to incubate for 1 hour in the dark. Plates were then washed three times, followed by addition of
the TMB Membrane Peroxidase Substrate (KPL, Gaithersburg, MD). After 30-40 minutes of
incubation in the dark (time length depended on the color reached by the positive controls), the
reaction was stopped with 2N sulfuric acid. Optical densities (ODs) were immediately read with
a Spectramax M2 spectrophotometer (Molecular Devices, Sunnyvale, CA) at 450 nm minus the
absorbance at 650 nm. Samples were run in duplicate and the mean ODs were calculated.
Samples were considered positive if the mean of the net ODs was greater than the mean OD of
the negative controls plus three standard deviations.
2.2.9. Statistical Analysis
All statistical analysis was performed using GraphPad Software (Prism 5 for Mac OS X,
La Jolla, California). For all comparisons, a P-value of <0.05 was considered significantly
different.
2.3. Results
2.3.1. Detection and Quantification of Rickettsia felis in cat flea feces
Based on two replicates, all experimental cat fleas taken at all time points [7, 14, 21, and
28 days post-exposure (DPE)] of the study were positive for R. felis genomic DNA (via qPCR
amplification of R. felis ompB), depicting a 100% infection rate of cat fleas following exposure
to an infectious bloodmeal. This infection was detected as early as 7 days post-exposure and
remained for the entirety of the study (28 days post-exposure). No cat fleas from control cages
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showed amplification of rickettsial DNA. Similarly, “prepared” flea feces taken from all time
points from experimental cages was positive for R. felis genomic DNA, at varying rates (Table
1). The overall mean from both replicates for all time points was 1.34x106 organisms per
milligram of flea feces, with a range of 9.93x104 to 3.5x106 organisms per milligram of flea
feces. The results from both trials were statistically analyzed to evaluate if there was a significant
difference in the number of rickettsial organisms present in the flea feces at different time points
(Figure 4). No significant differences were found via one-way ANOVA (P < 0.05) between any
of the time points.

Table 1. R. felis in infectious cat flea feces.
FECAL SAMPLE

R. FELIS DNA

R. FELIS RNA

7 DPE

4.02E5 (3.02E5 – 5.02E5)

+

14 DPE

1.5E6 (9.93E4 – 2.99E6)

+

21 DPE

1.26E6 (4.34E5 – 2.1E6)

+

28 DPE

2.19E6 (8.87E5 – 3.5E6)

+

DNA results shown in R. felis number of organisms per mg of feces (based on qPCR
amplification of R. felis ompB). A “+” under RNA results indicates there was amplification of
rickettsial cDNA prepared from isolated RNA samples. Data based on two replicates.
To assess the viability of rickettsiae, and thus potential infectivity, the cat flea feces were
analyzed for the presence of rickettsial transcripts. Flea feces collected at all time points in both
replicates showed amplification of R. felis ompB from prepared cDNA, indicating that rickettsial
transcripts, and potentially viable rickettsiae, were present at all time points (Table 1). The
amount of rickettsial RNA was not assessed in this study. All no-RT samples were negative for
presence of R. felis gene products.
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Figure 4. Number of R. felis organisms present per milligram of flea feces.
The data represents the number of organisms that are present per milligram of flea feces, based
on qPCR results. Time periods represent days post-exposure (DPE) to infectious bloodmeal. No
statistical differences were found between replicates.

2.3.2. Detection of Rickettsia felis in mouse tissue
For all three replicates, gDNA extractions were performed on all tissues (including skin
at and away from the inoculation site, heart, liver, spleen, and blood) from 24- and 48-hours
post-intradermal inoculation and were analyzed via qPCR for R. felis ompB amplification (Table
2). For the mice injected with R. felis from culture, at 24- and 48-hours post inoculation, 68%
(17/25) of skin samples taken from the inoculation site were positive for R. felis gDNA, while
16% (4/25) of skin samples taken away from the inoculation site were positive. Two samples
from the heart (8%) and one blood sample (4%) out of 25 also were qPCR-positive for R. felis
ompB gene amplification. No liver or splenic samples taken from any time points were positive
(0%; 0/25). One of the gDNA extraction environmental controls for 1 time point (correlating to
5 experimental mice at 24-hours post-inoculation) showed minor amplification of R. felis ompB,
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and therefore the corresponding experimental mice were not included in any of the presented
data. All other control mice and environmental controls were negative. For the mice injected
with R. felis-infected flea feces, at 24- and 48-hours post injection, 33% (10/30) of skin samples
taken from the inoculation site were positive, and 13% (4/30) of skin samples taken away from
the inoculation site were positive. No liver, splenic, heart, or blood samples from any time points
from mice injected with R. felis-infected flea feces were qPCR-positive for R. felis ompB gene
amplification. No experimental controls or control mice were positive. All samples that showed
late amplification (> cycle 35) were run on a gel to obtain a band for confirmation. Sequencing
revealed 100% identity to the R. felis ompB gene (Ascension KX090279.1) for all samples that
were considered positive. No bands were visualized for environmental controls or control mice.

Table 2. Mouse samples positive for R. felis gDNA via qPCR.
Tissue

Samples positive for R. felis
R. felis from culture

R. felis-infected feces

Skin at inoculation site

17/25 (68%)

10/30 (33%)

Skin away from inoculation site

4/25 (16%)

4/30 (13%)

Heart

2/25 (8%)

0/30 (0%)

Spleen

0/25 (0%)

0/30 (0%)

Liver

0/25 (0%)

0/30 (0%)

Blood

1/25 (4%)

0/30 (0%)

Samples are from mice sacrificed at 24- and 48-hours post-intradermal inoculation. Data based
on three replicates. All control mice (injected with either L15B total media or R. felis-free flea
feces) and environmental controls were negative for the presented data.
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Detection of R. felis gDNA at the site of inoculation was significantly higher in mice
injected with R. felis from culture compared to mice injected with R. felis-infected flea feces
(unpaired t-test, P < 0.05). However, no statistically significant difference was found in R. felis
qPCR detection in skin away from the inoculation site between experimental groups.
The data presented represents three replicates of mice injected with R. felis-infected flea
feces that was collected and analyzed within 24 hours of inoculation, while being maintained in
the artificial dog unit until time of injection. The first trial (not included in the data) used
previously frozen R. felis-infected flea feces. No tissue samples from any of the time points from
this trial showed amplification of R. felis ompB via qPCR. This was presumed due to lack of
bacterial viability (after freezing and thawing), so future experiments all used unfrozen, fresh
“prepared” feces.
To assess potential viability of the rickettsial organisms present, RNA isolation and
cDNA synthesis, followed by amplification of R. felis ompB from cDNA, was performed on the
skin samples that tested positive for R. felis gDNA via qPCR. No rickettsial transcripts were
detected in any of the skin samples tested from 24- and 48-hours post-inoculation.
2.3.3. Gross Pathology
One mouse injected with R. felis from culture (at 48-hours post-injection) had a pinpoint,
erythematous lesion at the injection site (Figure 5). This lesion did correlate with a skin sample
that tested positive for R. felis gDNA via qPCR and IHC. All other tissues and all other
necropsies on mice (including mice injected with R. felis from culture and R. felis-infected flea
feces) were unremarkable (Figure 6). No mice developed any overt physical or clinical signs
throughout the course of the experiments.
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Figure 5. Pinpoint lesion on mouse infected with R. felis from culture.
One mouse injected with R. felis from culture had a pinpoint, erythematous, scab-like lesion (red
arrow) at the site of inoculation. This correlated with skin the tested positive for R. felis gDNA
via qPCR and IHC.

Figure 6. Representative photo of mouse skin post-intradermal inoculation.
With one exception (shown in Figure 5), all mice showed no visible gross lesions at either 24
hours, 48 hours, or 14 days post-intradermal inoculation with either R. felis from culture or R.
felis-infected flea feces.
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2.3.4. Histopathology and Immunohistochemistry (IHC)
All sections of tissue that showed amplification of rickettsial DNA via qPCR, including
35 sections of skin and two sections of heart from mice sacrificed 24- and 48-hours postinoculation, were analyzed via histopathology and IHC. Control sections from corresponding
tissues were also analyzed. For mice injected with R. felis from culture, histopathological
evaluation revealed mild to occasionally moderate, deep dermatitis and panniculitis
predominated by macrophages and lymphocytes, with lower numbers of neutrophils and rare
plasma cells and mast cells (Figure 7). Some edema was also noted, and occasional inflammatory
cells infiltrated the panniculus carnosus muscle (myositis). The control mice from this portion of
study (that were injected with L15B total media alone) showed no histopathological changes.
Using the scoring system as previously described, the mean histopathological score for mice
injected with R. felis from culture (1.69+) was significantly greater than that of the control mice
(0) at the inoculation site via an unpaired t-test (P < 0.05).
Mice injected with R. felis-infected flea feces showed moderate to occasionally severe,
suppurative deep dermatitis and panniculitis, with lower numbers of mononuclear cells.
Extension into the muscle (myositis) was also occasionally seen. Few samples had focal to
extensive liquefactive necrosis (Figure 8), characterized by pyknotic and karyorrhectic debris
mixed with viable and degenerate neutrophils and extensive fibrin deposition. Control mice
from this portion of the study (that were injected with R. felis-free cat flea feces) showed similar
histopathologic changes (Figure 9), with the exception of liquefactive necrosis, which was absent
in the control sections. A significant difference was not found between the mean
histopathological scores for experimental mice (2.37+) and control mice (3+). Compared to skin
sections from mice injected with R. felis from culture (1.69+), mice injected with R. felis-infected
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Figure 7. Histopathology of mouse skin post-inoculation with R. felis from culture.
Photomicrographs of an H&E stained skin section taken from the site of inoculation (100x; Inset:
400x). There is mild to moderate deep dermatitis and panniculitis, characterized by
predominantly mononuclear cells (including macrophages and lymphocytes- depicted in the
inset), with fewer neutrophils and scattered mast cells and plasma cells. There is also cell
infiltration into the underlying panniculus carnosus muscle (myositis- red circle).
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Figure 8. Histopathology of mouse skin post-inoculation with R. felis-infected flea feces.
Photomicrographs of an H&E stained skin section of mouse tissue taken from the site of
inoculation (100x; Inset 400x). There is severe suppurative dermatitis and panniculitis with
liquefactive necrosis, characterized by a dense band subjacent to the panniculus carnosus of
viable and degenerate neutrophils mixed with karyorrhectic and pyknotic cellular debris.
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Figure 9. Histopathology of mouse skin post-inoculation with R. felis-free flea feces.
Photomicrographs of an H&E stained skin section taken from the site of inoculation. A. (100x)
Mice injected with R. felis-free flea feces showed moderate to marked, deep dermatitis and
panniculitus, consisting predominantly of neutrophils (B- 400x), and fewer mononuclear cells.

flea feces (2.37+) showed a greater histopathological score (unpaired t-test, P < 0.05). No
histopathological changes were noted in any of the heart sections examined.
For immunohistochemistry, only few samples showed rare positively staining
coccobacilli (Figure 10). Three samples (3/25; 12%) of skin taken from the inoculation site from
mice injected with R. felis from culture revealed rare organisms (+), and one sample (1/30; 3%)
from the inoculation site from a mouse infected with R. felis-infected feces had rare organisms
(+). The organisms were visualized both within macrophages and neutrophils, and occasionally
appeared to be extracellular. Positive and negative control slides showed appropriate labeling.
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Figure 10. Anti-Rickettsia immunohistochemistry of mouse skin post-inoculation with R. felis
from culture.
Photomicrographs of a skin section stained with a polyclonal anti-Rickettsia antibody. A: The
skin sections revealed mild to moderate histiocytic to lymphocytic dermatitis (100x). B and C:
Rare positive, brown-staining rickettsial organisms (red arrows) were seen within macrophages,
neutrophils, and possibly the extracellular space (1000x; oil immersion).

2.3.5. ELISA Results
Serum from mice sacrificed at 14-days post-inoculation were analyzed via indirect
ELISAs to detect the presence of rickettsial antibodies. At a 1:32 dilution, 8/10 (80%) mice
injected with R. felis-infected flea feces had measurable levels of anti-Rickettsia IgG, whereas
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only 1/9 (11%) of animals injected with R. felis from culture had detectable levels. At a 1:64
dilution, only 2/10 (20%) of mice injected with R. felis-infected feces had detectable levels, and
no mice with injected with R. felis from culture had measurable anti-Rickettsia IgG titers. AntiRickettsia IgG was not detected in any control mice at significant levels (greater than 3 standard
deviations above the mean ODs of the negative control). The number of mice with a measurable
IgG response at a 1:32 dilution was significantly higher in the R. felis-infected feces group
compared to the R. felis from culture group (unpaired t-test, P < 0.05).
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CHAPTER 3: DISCUSSION & FUTURE DIRECTIONS
In this study, cutaneous inoculation with feces from cat fleas infected with R. felis was
found to be an effective transmission medium for the organism to mice, supported both by the
detection of high numbers of viable rickettsiae in infected flea feces, as well as the presence of R.
felis gDNA within the skin of mice inoculated with infectious feces. The response of these
animals to intradermally injected R. felis-infected flea feces is characterized by primarily a
neutrophilic dermatitis, as well as a positive anti-Rickettsia IgG response at 14 days postexposure. However, there were no physical or clinical changes associated with the transmission
of R. felis through infectious cat flea feces, and no systemic dissemination of the organism was
documented through this route.
The first step in determining transmission of R. felis through infectious arthropod feces
included confirming the presence of viable Rickettsia in cat flea feces. This study found that R.
felis gDNA was present in high numbers in cat flea feces as early 7 days-post exposure (DPE) to
an infectious bloodmeal and remained present for the rest of the experiment (up to 28 DPE).
These findings confirm what was shown in a previous study where rickettsial gDNA was found
in cat flea feces at all time points post-exposure to an infectious bloodmeal [22]. The average
number of rickettsiae (based on qPCR amplification of the R. felis ompB gene) in this study was
found to be 1.34x106 organisms per milligram of flea feces. This number is higher than what was
found in a preliminary study (4x104 organisms/milligram) using high passage R. felis (LSU;
passage 8) for cat flea infections [Legendre, Unpublished]. Because the data from the
preliminary study was used in the calculation of the infectious dose for mice attempting to
mimick a “natural” infection, it is possible that the dose used for inoculation of mice was
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actually lower than what could be expected in nature. Future studies examining varying
inoculation dosages might result in different findings in vertebrate inoculations.
The presence of rickettsial transcripts within the cat flea feces at all time points,
indicating potentially viable organisms, is a novel finding, as a previous experiment showed
rickettsial transcripts were present only at 21 DPE [22]. This discrepancy is likely due to the
advent of more sensitive RNA techniques that have developed since previous experiments were
performed. Additionally, even though all time points had evidence of potentially viable R. felis
organisms, there is the potential that feces taken from different DPE may have varying effects
upon inoculation into vertebrates. This assumption is based on previous work done with R. typhi,
where rats demonstrated seroconversion after intraperitoneal injection with flea feces only when
the feces was obtained over 10 days post-flea infection [39]. For this reason, all vertebrate
experiments were performed using feces taken from 14 DPE. This time point was chosen as
opposed to 7 DPE because it has been suggested that early detection of R. felis gDNA in flea
feces might be secondary to lysis of heavily infected midgut epithelial cells in fleas in early
infection, as opposed to live, actively replicating, organisms [22, 23]. Later time points (i.e. 21
DPE or 28 DPE) were not chosen for ease of experimental conditions. It is possible that the use
of flea feces taken from varying time points post-exposure to an infectious bloodmeal may have
produced different results in vertebrate inoculations.
Overall, R. felis from culture seemed to persist and possibly disseminate more efficiently
in mice than R. felis within infectious flea feces. This is supported by the increased number of
mice that had detectable levels of R. felis at the site of inoculation 24- and 48-hours post
inoculation (68% compared to 33%), as well as the rare animals that had detectable levels of R.
felis within the heart and blood when injected with R. felis from culture. While dissemination in
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the animals injected with R. felis from culture could not be confirmed via staining of the
organisms with IHC, it is suspected that the low number of bacteria present (detected via qPCR
amplification) precluded immunohistochemical labeling, as IHC is not as sensitive as PCR for
the detection of most organisms. The increased persistence and possible dissemination in the
animals injected with R. felis from culture is likely due to a decreased immune response to the
bacteria alone compared to the bacteria within flea feces. Mice injected with R. felis-infected flea
feces exhibited a more severe cutaneous reaction (characterized by a moderate to severe
suppurative dermatitis) compared to the mice injected with R. felis from culture. Additionally, a
positive anti-Rickettsia IgG response (at a 1:32 dilution) was found more commonly in mice
injected with R. felis-infected feces than R. felis from culture (80% vs. 20%, respectively). These
findings suggest that the flea feces acted as a potential adjuvant and increased the animals’
immune responses to the injected bacteria, leading to an increased clearance and lack of
dissemination.
The low numbers of organisms detected via qPCR amplification is also thought to be the
reason that no rickettsial transcripts were found in the skin of mice injected with R. felis from
culture or R. felis-infected flea feces. As RNA is much more difficult to extract and detect than
DNA, our conclusion remains that viable rickettsiae were intradermally inoculated into the mice.
This idea is supported by the fact that detection of R. felis gDNA in the skin of mice injected
with R. felis-infected flea feces was precluded when the flea feces were previously frozen,
corroborating the thought that only viable rickettsiae could persist in the skin within detectable
limits of qPCR amplification for 24 to 48 hours. Future studies with a higher inoculation dose
that would increase the levels of bacteria within the skin, and thus likely increase the chances of
RNA detection, would help confirm this hypothesis.
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BALB/c mice were chosen as a murine model organism for vertebrate inoculations based
on the previous findings that this strain produced a detectable rickettsemia post-intraperitoneal
injection with R. felis from culture [32]. BALB/c mice are particularly well known for their
demonstration of Th2-biased immune responses [47]. Rickettsial bacteria are intracellular
organisms which target endothelial cells and macrophages [48], and therefore primarily induce a
Th1 immune response, requiring the generation of cytotoxic T lymphocytes for protective
immunity. In this sense, BALB/c mice could possibly be immunodeficient in regards to
rickettsial killing if they favor a Th2 response. This work is clearly a preliminary study, and
future use of different vertebrates (including alternate strains of mice, other rodents, and even
larger vertebrates) will likely produce varying results.
The lack of physical changes, especially at the site of cutaneous inoculation with R. felis
–infected flea feces, was a surprising finding. However, the histologic changes noted in the skin
of the injected mice were all deep within the dermis and underlying subcutaneous tissue, with no
evidence of epidermal changes, which supports the lack of gross findings. An ideal animal model
for studying a disease would mimic the physical and clinical signs observed in the human
disease. However, given the wide range of described clinical presentations for human flea-borne
spotted fever, it is difficult to accurately assess if an animal model is appropriate. It could be
suggested that the response of the mice in this study injected intradermally with R. felis-infected
flea feces most closely resembles the “yaaf” disease entity, supported by the amplification of R.
felis gDNA from skin at the inoculation site and anti-Rickettsia IgG titers 14 days post-injection.
However, these mice clearly lacked cutaneous lesions or any other systemic signs. While the
most common reported accompanying symptom in humans was a fever, and mouse body
temperatures were never assessed, mice never showed any clinical signs that warranted further
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physical examination (e.g. ruffled fur, lethargy, squinted eyes). Lack of epidermal changes, and
thus gross lesions, could be secondary to the route of inoculation (intradermal injections) of the
infectious flea feces. Another cutaneous route of inoculation, such as introduction of infectious
flea feces into open dermal wounds or puncture of the epidermis with an infectious flea fecesladen object, could produce similar lesions to what is observed in the human disease.
Overall, this study shows that high numbers of viable rickettsiae are excreted in cat flea
feces infected with R. felis. These viable bacteria, along with the flea feces, can be introduced
into vertebrates via intradermal injection and produce a measurable response, consisting of a
moderate to severe suppurative dermatitis and a positive anti-Rickettsia IgG titer. Future work
with varying inoculation doses, additional vertebrate models, and alternative cutaneous infection
routes may prove helpful in determining the role of these infectious arthropod feces in the
epidemiology of human flea-borne spotted fever.
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